Sleep-disordered breathing in obese children is associated with prevalent excessive daytime sleepiness, inflammation, and metabolic abnormalities

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 1, 2010, Pages 143-150

  Tsaoussoglou, Marina ^a,b   Bixler, Edward O ^a   Calhoun, Susan ^a   Chrousos, George P ^b   Sauder, K ^a   Vgontzas, Alexandros N ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SCHOOL CHILD; SLEEP DISORDERED BREATHING;

EID: 75149183118     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0435     Document Type: Article

References (47)

1. Lumeng JC, Chervin RD 2008 Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc 5:242-252
2. Bixler EO, Vgontzas AN, Lin HM, Liao D, Calhoun S, Fedok F, Vlasic V, Graff G 2008 Blood pressure associated with sleep-disordered breathing in a population sample of children. Hypertension 52:841-846
3. Ogden CL, Carroll MD, Flegal KM 2008 High body mass index for age among US children and adolescents, 2003-2006. JAMA 299: 2401-2405
4. Vgontzas AN, Bixler EO, Tan TL, Kantner D, Martin LF, Kales A 1998 Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med 158:1333-1337
5. Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A 2005 Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 90:4510-4515
6. Gozal D, Kheirandish-Gozal L 2007 Neurocognitive and behavioral morbidity in children with sleep disorders. Curr Opin Pulm Med 13:505-509
7. Gozal D 1998 Sleep-disordered breathing and school performance in children. Pediatrics 102:616-620
8. Gozal D, Wang M, Pope Jr DW 2001 Objective sleepiness measures in pediatric obstructive sleep apnea. Pediatrics 108:693-697
9. Melendres MC, Lutz JM, Rubin ED, Marcus CL 2004 Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics 114:768-775
10. Carroll JL, McColley SA, Marcus CL, Curtis S, Loughlin GM1995 Inability of clinical history to distinguish primary snoring from obstructive sleep apnea syndrome in children. Chest 108:610-618
11. Chervin RD, Weatherly RA, Ruzicka DL, Burns JW, Giordani BJ, Dillon JE,MarcusCL,Garetz SL,HobanTF,Guire KE 2006 Subjective sleepiness and polysomnographic correlates in children scheduled for adenotonsillectomy vs. other surgical care. Sleep 29:495-503
12. Gozal D, Kheirandish-Gozal L 2009 Obesity and excessive daytime sleepiness in prepubertal children with obstructive sleep apnea. Pediatrics 123:13-18
13. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP 1997 Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82:1313-1316
14. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP 2000 Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85:1151-1158
15. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP 2004 Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 89:4409-4413
16. Tauman R, O'Brien LM, Gozal D 2007 Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing. Sleep Breath 11:77-84
17. Tauman R, Ivanenko A, O'Brien LM, Gozal D 2004 Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 113:e564 - e569
18. Larkin EK, Rosen CL, Kirchner HL, Storfer-Isser A, Emancipator JL, Johnson NL, Zambito AM, Tracy RP, Jenny NS, Redline S 2005 Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 111:1978-1984
19. Tam CS, Wong M, McBain R, Bailey S, Waters KA 2006 Inflammatory measures in children with obstructive sleep apnoea. J Paediatr Child Health 42:277-282
20. Kaditis AG, Alexopoulos EI, Kalampouka E, Kostadima E, Germenis A, Zintzaras E, Gourgoulianis K 2005 Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 171:282-286
21. Bixler EO, Vgontzas AN, Lin H-M, Liao D, Calhoun S, Vela-Bueno A, Fedok F, Vlasic V, Graff G 2009 Sleep-disordered breathing in children in a general population sample: prevalence and risk factors. Sleep 32:731-736
22. Chervin RD, Hedger K, Dillon JE, Pituch KJ 2000 Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med 1:21-32
23. American Thoracic Society 1996 Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med 153:866-878
24. American Academy of Pediatrics 2002 Clinical practice guidelines: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 109:704-712
25. Centers for Disease Control and Prevention http://www.cdc.gov/ growthcharts/clinical-charts.htm
26. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM 2006 Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:1549-1555
27. Williams J, Wake M, Hesketh K, Maher E, Waters E 2005 Health-related quality of life of overweight and obese children. JAMA 293: 70-76
28. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S 2004 Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362-2374
29. Goodwin JL, Kaemingk KL, Fregosi RF, Rosen GM, Morgan WJ, Sherrill DL, Quan SF 2003 Clinical outcomes associated with sleepdisordered breathing in Caucasian and Hispanic children - the Tucson children's assessment of sleep apnea study (TuCASA). Sleep 26:587-591
30. Stepanski E, Zayyad A, Nigro C, Lopata M, Basner R 1999 Sleep disordered breathing in a predominantly African-American pediatric population. J Sleep Res 8:65-70
31. Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G 1999 Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 159:1527-1532
32. Morton S, Rosen C, Larkin E, Tishler P, Aylor J, Redline S 2001 Predictors of sleep-disordered breathing in children with a history of tonsillectomy and/or adenoidectomy. Sleep 24:823-829
33. Opp MR 2005 Cytokines and sleep. Sleep Med Rev 9:355-364
34. Kapas L, Hong L, Cady AB, Opp MR, Postlethwaite AE, Seyer JM, Krueger JM 1992 Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-α and TNF-α fragments. Am J Physiol 263: 708-715
35. Mastorakos G, Chrousos GP, Weber JS 1993 Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77:1690-1694
36. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT 2003 Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 163:565-571
37. Ryan S, Taylor CT, McNicholas WT 2005 Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660-2667
38. Vgontzas AN, Zoumakis E, Bixler EO, LinHM,Collins B, Basta M, Pejovic S, Chrousos GP 2008 Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 38:585-595
39. Mehra R, Storfer-Isser A, Kirchner HL, Johnson N, Jenny N, Tracy RP, Redline S 2006 Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med 166:1725-1731
40. Tauman R, Serpero LD, Capdevila OS, O'Brien LM, Goldbart AD, Kheirandish-Gozal L, Gozal D 2007 Adipokines in children with sleep disordered breathing. Sleep 30:443-449
41. Shamsuzzaman AS, Winnicki M, Wolk R, Svatikova A, Phillips BG, Davison DE, Berger PB, Somers VK 2004 Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109:2181-2185
42. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, Bloom S, Stevenson JC 1998 Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 18:928-933
43. Gilardini L, McTernan PG, Girola A, da Silva NF, Alberti L, Kumar S, Invitti C 2006 Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis189:401-407
44. Cruz M, García-Macedo R, García-Valerio Y, Gutiérrez M, Medina-Navarro R, Duran G, Wacher N, Kumate J 2004 Low adiponectin levels predict type 2 diabetes in Mexican children. Diabetes Care 27:1451-1453
45. Spranger J, Kroke A,Möhlig M, BergmannMM,Ristow M, Boeing H, Pfeiffer AF 2003 Adiponectin and protection against type 2 diabetes mellitus. Lancet [Erratum (2002) 361:1060] 361:226-228
46. Verhulst SL, Rooman R, Van Gaal L, De Backer W, Desager K 2009 Is sleep-disordered breathing an additional risk factor for the metabolic syndrome in obese children and adolescents? Int J Obes 33:8-13
47. Vgontzas AN, Bixler EO, Chrousos GP 2005 Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9:211-224